The flu season is on again. According to the CDC, between 5 percent and 20 percent of the U.S. population develops influenza each year. This leads to more than 200,000 hospitalizations from related complications. Influenza seasons are unpredictable and can be severe, with annual influenza-related deaths ranging from a low of about 3,000 to a high of 49,000 people in the U.S. The CDC’s Advisory Committee on Immunization Practices, recommends that everyone six months of age and older receive an annual influenza vaccine.
In addition to influenza, RSV and norovirus peak seems to be approaching. When it comes to the preventation of respiratory diseases, a quick and correct diagnosis is crucial. Therefore, world respiratory markets are keen on having new innovative solutions to fight the diseases.
Innomedica has experience and connections to support your business development in this field.